Publications by authors named "Mark Pletscher"

Claim this Profile
S
Systematic review of cost-effectiveness modelling studies for haemophilia.
Niklaus Meier, Daniel Ammann, Mark Pletscher, Jano Probst, Matthias Schwenkglenks

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized Treatment Rules Based on Cost-Effectiveness Criteria in Microsimulations.
Niklaus Meier, Ana Cecilia Quiroga Gutierrez, Mark Pletscher, Matthias Schwenkglenks

Pharmacoeconomics· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to comment by Arber C, et al. on: Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland.
Maria Trottmann, Eva Blozik, Marcel Hilbig, Mark Pletscher, Niklaus Meier

Swiss Med Wkly· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Versus Extended Half-Life Prophylaxis for Moderate-to-Severe Haemophilia B in Germany.
Niklaus Meier, Hendrik Fuchs, Katya Galactionova, Cedric Hermans, Mark Pletscher

Pharmacoecon Open· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Separating the wheat from the chaff: How to measure hospital quality in routine data?
Jana Bilger, Mark Pletscher, Tobias Müller

Health Serv Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of seasonal influenza in the Swiss adult population during the 2016/2017-2018/2019 influenza seasons.
Daniel Ammann, Jana Bilger, Matthew M Loiacono, Susanne G Oberle, Andreas Dounas, Mark Pletscher

Influenza Other Respir Viruses· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data.
Maria Trottmann, Eva Blozik, Marcel Hilbig, Daniel LoVerdi, Marcello Pedruzzi, Mark Pletscher

Swiss Med Wkly· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine.
François R Girardin, Antoine Poncet, Arnaud Perrier, Nathalie Vernaz, Mark Pletscher

Pharmacogenomics J· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How much does the treatment of each major disease cost? A decomposition of Swiss National Health Accounts.
Simon Wieser, Marco Riguzzi, Mark Pletscher, Carola A Huber, Harry Telser

Eur J Health Econ· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of organized screening programs on the demand for mammography in Switzerland.
Mark Pletscher

Eur J Health Econ· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marginal revenue and length of stay in inpatient psychiatry.
Mark Pletscher

Eur J Health Econ· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of functional cardiac imaging in the diagnostic work-up of coronary heart disease.
Mark Pletscher, Simon Walker, Karine Moschetti, Christophe Pinget, Jean-Blaise Wasserfallen

Eur Heart J Qual Care Clin Outcomes· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health utility indexes in patients with acute coronary syndromes.
Baris Gencer, Nicolas Rodondi, Reto Auer, David Nanchen, Lorenz Räber, Mark Pletscher

Open Heart· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Societal Costs of Schizophrenia in Switzerland.
Mark Pletscher, Renato Mattli, Agnes von Wyl, Oliver Reich, Simon Wieser

J Ment Health Policy Econ· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland.
Mark Pletscher, Rafael Plessow, Klaus Eichler, Simon Wieser

Swiss Med Wkly· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of acute coronary syndrome in Switzerland in 2008.
Simon Wieser, Isabelle Rüthemann, Sylvia De Boni, Klaus Eichler, Mark Pletscher

Swiss Med Wkly· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis